Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rentokil
RTO
|
+$514M |
| 2 |
APLS
Apellis Pharmaceuticals
APLS
|
+$210M |
| 3 |
TFI International
TFII
|
+$145M |
| 4 |
Ambev
ABEV
|
+$142M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$133M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.7B |
| 3 |
Amazon
AMZN
|
+$3.72B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.64B |
| 5 |
Mastercard
MA
|
+$3.47B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.73% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
USER
676
DELISTED
UserTesting, Inc.
USER
| $12.2M | 0.01% |
+1,629,345
| New | +$10.4M |
|
|
MGI
677
DELISTED
MoneyGram International, Inc. New
MGI
| $12.2M | 0.01% |
1,123,101
-662,343
| -37% | -$7.09M |
|
678
General Motors
GM
$80B
| $12.2M | 0.01% |
363,365
-363,399
| -50% | -$13.4M |
|
679
ACI Worldwide
ACIW
$5.86B
| $12.2M | 0.01% |
531,232
+488,296
| +1,137% | +$10.5M |
|
680
Cigna
CI
$76.1B
| $12.2M | 0.01% |
36,778
-35,472
| -49% | -$11.2M |
|
681
P3 Health Partners
PIII
$34M
| $12.2M | 0.01% |
132,458
| – | – |
|
|
DEA
682
Easterly Government Properties
DEA
$1.15B
| $12.1M | 0.01% |
339,361
-574,636
| -63% | -$22.4M |
|
683
Kimberly-Clark
KMB
$36.6B
| $12.1M | 0.01% |
89,123
+11,201
| +14% | +$1.42M |
|
684
3M
MMM
$90.8B
| $11.9M | 0.01% |
118,353
-54,469
| -32% | -$5.55M |
|
685
Hain Celestial
HAIN
$44.4M
| $11.8M | 0.01% |
730,812
-890,658
| -55% | -$15.9M |
|
686
West Fraser Timber
WFG
$4.99B
| $11.8M | 0.01% |
163,180
-125,020
| -43% | -$9.53M |
|
687
Exelon
EXC
$46.6B
| $11.8M | 0.01% |
272,936
-171,530
| -39% | -$6.78M |
|
688
Enbridge
ENB
$121B
| $11.8M | 0.01% |
301,687
-314,315
| -51% | -$12.3M |
|
689
Chubb
CB
$135B
| $11.5M | 0.01% |
52,276
-132,884
| -72% | -$27.6M |
|
690
Xenon Pharmaceuticals
XENE
$6.2B
| $11.5M | 0.01% |
291,786
-175,882
| -38% | -$6.4M |
|
691
CRA International
CRAI
$1.19B
| $11.4M | 0.01% |
93,141
+89,300
| +2,325% | +$9.84M |
|
|
TBCP
692
DELISTED
Thunder Bridge Capital Partners III Inc. Class A Common Stock
TBCP
| $11.4M | 0.01% |
1,159,220
-1,158,920
| -50% | -$11.5M |
|
693
Design Therapeutics
DSGN
$788M
| $11.3M | 0.01% |
1,105,859
-1,901,763
| -63% | -$25.8M |
|
694
Stem
STEM
$47.5M
| $11.3M | 0.01% |
63,445
-65,096
| -51% | -$15.6M |
|
695
HDFC Bank
HDB
$124B
| $11.3M | 0.01% |
330,252
-390,908
| -54% | -$12.7M |
|
696
Baxter International
BAX
$13.8B
| $11.3M | 0.01% |
221,614
+107,818
| +95% | +$5.79M |
|
697
QuantumScape Corp
QS
$3.22B
| $11.3M | 0.01% |
1,986,169
-1,805,713
| -48% | -$13.4M |
|
698
Eaton
ETN
$150B
| $11.2M | 0.01% |
71,359
-70,175
| -50% | -$10.8M |
|
699
Consolidated Edison
ED
$40.4B
| $11.1M | 0.01% |
116,423
-126,857
| -52% | -$11.5M |
|
|
WRK
700
DELISTED
WestRock Company
WRK
| $11.1M | 0.01% |
315,598
-1,037,478
| -77% | -$36.2M |
|
Similar funds
Janus Henderson Group's Q4 2022 Portfolio in Review
As of Q4 2022, Janus Henderson Group held 2,666 positions worth $140B, down 48% from $267B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Janus Henderson Group withdrew a net $148B in Q4 2022, closing 210 positions and reducing 1,907 holdings. Its most notable exit was Terminix Global Holdings, Inc., an estimated $901M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Janus Henderson Group opened a new position in Rentokil worth $510M.
- Janus Henderson Group's largest Q4 2022 buy was Rentokil: 16,564,405 shares worth $510M.
- Janus Henderson Group added most to Apellis Pharmaceuticals in Q4 2022, an estimated $210M increase.
- Janus Henderson Group's biggest Q4 2022 reduction was Microsoft, cutting an estimated $8.38B.
- Janus Henderson Group fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $901M.
- Janus Henderson Group's ten largest holdings make up 22% of its $140B portfolio in Q4 2022.
- Janus Henderson Group opened 131 new positions and closed 210 in Q4 2022.
- Janus Henderson Group's portfolio value fell 48% quarter-over-quarter to $140B.
Based on Janus Henderson Group's 13F filing for Q4 2022, filed 14 Feb 2023.